Pathogens without payback: when sharing isn’t caring

Low- and middle-income countries where new pathogens often emerge, are expected to proactively share biological materials and genomic data with the world. However, countries that develop life-critical vaccines, therapeutics and diagnostics using that material are under no obligation to reciprocate with fair and timely access to these clinical products. Image used for representational purposes only
| Photo Credit: Getty Images